US Edition
News from drugtopics.com
We’ve assigned a rating of Unknown factuality to drugtopics.com. You can read more about how we’ve determined drugtopics.com’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top drugtopics.com News
Hepatitis B · United StatesA federal vaccine advisory committee has voted to end a longstanding recommendation that all U.S. babies get the hepatitis B vaccine on the day they’re born.See the Story
US vaccine advisers say not all babies need a hepatitis B shot at birth
54% Center coverage: 358 sources
Health · United StatesU.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by postmenopausal women up to 65 years old.See the Story
FDA OKs libido-boosting pill for older women who have gone through menopause
62% Center coverage: 51 sources
Health Care · United States(MedPage Today) -- The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone Pharmaceuticals announced.
The rapid-acting L-type calcium channel blocker is indicated...See the Story
Etripamil Gets FDA Approval for At-Home Tachycardia Conversion
100% Center coverage: 1 sources
